TII-SSRC-23 DATASET: TYPOLOGICAL EXPLORATION OF DIVERSE TRAFFIC PATTERNS FOR INTRUSION DETECTION





Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis

Abstract Background Immune checkpoint inhibitors (ICIs) have demonstrated superior clinical efficacy in prolonging overall survival (OS) as the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC), and were recommended Hat by the guidelines.However, it remains uncertain which ICI is the most cost-effective.This

read more